What is the recommended acute management and secondary prevention for an ischemic stroke?

Acute Management and Secondary Prevention of Ischemic Stroke

Acute Management

For acute ischemic stroke, immediately administer intravenous thrombolysis (if eligible within appropriate time windows) and perform endovascular thrombectomy for large vessel occlusions within 24 hours of symptom onset, as these interventions dramatically reduce disability and mortality. 1, 2

Prehospital and Emergency Care

• Rapid identification and triage to comprehensive stroke centers capable of delivering both IV thrombolysis and endovascular therapy is critical, as time directly correlates with outcomes 3
• Emergency medical services protocols should be used to identify stroke patients and activate stroke systems of care 1

Intravenous Thrombolysis

• Administer IV thrombolysis to eligible patients, with recent updates expanding eligibility criteria and treatment time windows 1, 2
• Treatment should be initiated as quickly as possible within the approved time window, as earlier treatment yields better outcomes 3
• The 2026 AHA/ASA guidelines provide updated recommendations on thrombolytic choice and contraindications 2

Endovascular Thrombectomy

• Perform mechanical thrombectomy with current stent retriever devices for patients with large vessel anterior circulation occlusions within 6 hours of presentation (number needed to treat: 3-7 for independent functional outcome) 4
• Advanced imaging with automated interpretation can identify patients with large areas of at-risk brain tissue who may benefit from thrombectomy in extended time windows up to 24 hours 3, 2
• Benefit is additive to IV thrombolysis alone 4

Acute Blood Pressure Management

• For acute ischemic stroke without reperfusion therapy: Avoid routine BP lowering unless SBP ≥220 mmHg or DBP ≥120 mmHg; if lowering is needed, reduce by only ~15% within 24 hours 5
• For patients receiving IV thrombolysis or thrombectomy: Maintain BP <185/110 mmHg before treatment and <180/105 mmHg during the first 24 hours 5
• Avoid excessive BP reduction, large variability, and overshoot to prevent worsening outcomes 5

Acute Physiologic Management

• Manage hyperglycemia appropriately, as the 2026 guidelines provide updated recommendations on glucose control 2
• Screen for and manage dysphagia early to prevent aspiration complications 2

Secondary Prevention

Antiplatelet Therapy for Non-Cardioembolic Stroke

For minor ischemic stroke or high-risk TIA, initiate dual antiplatelet therapy (aspirin plus clopidogrel) within 24 hours and continue for 21-90 days, as this significantly reduces early recurrent stroke risk. 6, 7

• Early stroke recurrence rates are substantially higher than long-term rates, reflecting a transient vulnerable state that requires acute intervention 6
• For large artery atherosclerosis with 70-99% stenosis of major intracranial artery: Add clopidogrel 75 mg/day to aspirin for up to 90 days 1
• Long-term maintenance: Continue single antiplatelet therapy (aspirin, clopidogrel, or aspirin-dipyridamole) indefinitely 1

Anticoagulation for Cardioembolic Stroke

For ischemic stroke with atrial fibrillation, prescribe direct oral anticoagulants (DOACs: apixaban, dabigatran, edoxaban, or rivaroxaban) in preference to warfarin, as they have superior safety and efficacy profiles. 1

• Apixaban demonstrated superiority in both safety and efficacy compared to warfarin 4
• For TIA with nonvalvular AF: Initiate anticoagulation immediately after the index event 1
• For stroke at high risk of hemorrhagic conversion: Delay oral anticoagulation beyond 14 days to reduce ICH risk 1
• Early initiation of DOACs in cardioembolic stroke shows benefits in preventing recurrence 6
• Prolonged cardiac monitoring (30 days to 1 year) is recommended for cryptogenic stroke to detect paroxysmal atrial fibrillation, as this diagnosis fundamentally changes management 4, 8

Blood Pressure Control

Target BP <130/80 mmHg for chronic secondary prevention after ischemic stroke, using thiazide diuretics, ACE inhibitors, or angiotensin receptor blockers as foundational therapy. 1, 5

• High-intensity statin therapy is recommended regardless of baseline cholesterol for patients with atherosclerotic stroke 1
• Early continuation or initiation of statins promotes stabilization of vulnerable arterial plaque 6

Specific Etiologies

Intracranial Atherosclerosis (50-99% stenosis)

• Aspirin 325 mg/day is preferred over warfarin 1
• Add clopidogrel for severe stenosis (70-99%) within 30 days for up to 90 days 1
• Maintain SBP <140 mmHg and prescribe high-intensity statin 1
• Angioplasty and stenting should NOT be performed as initial treatment due to excess morbidity and mortality 1

Carotid Stenosis

• Procedural management (carotid endarterectomy or stenting) may be indicated for symptomatic severe stenosis 8

Patent Foramen Ovale

• Closure may be indicated in selected patients with cryptogenic stroke 8

Lifestyle and Risk Factor Modification

• At least moderate physical activity is recommended 1
• Healthy diet, regular exercise, avoidance of substance use 8
• Treatment of obstructive sleep apnea if present, as prolonged cardiac monitoring can detect this modifiable risk factor 4, 8
• Blood glucose control for diabetic patients 8

Common Pitfalls

• Do not delay reperfusion therapy for extensive workup; time is brain 3
• Do not use dual antiplatelet therapy long-term beyond 90 days due to bleeding risk 7
• Do not perform intracranial stenting as first-line therapy even in "medical failures" 1
• Do not overlook cardiac monitoring in cryptogenic stroke, as up to 25% may have undetected atrial fibrillation requiring anticoagulation rather than antiplatelet therapy 4, 8
• Reperfusion therapies do not increase early recurrent stroke or thrombotic events compared to medical management alone 9